Biomarker approach harnessed in trials of personalized medicine for bladder cancer
Crossref DOI link: https://doi.org/10.1038/s41591-021-01300-1
Published Online: 2021-05-03
Published Print: 2021-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dizman, Nazli
Meza, Luis http://orcid.org/0000-0002-0235-297X
Pal, Sumanta K.
Text and Data Mining valid from 2021-05-01
Version of Record valid from 2021-05-01
Article History
First Online: 3 May 2021
Competing interests
: N. D. reports consulting for Vivreon Bioscience. S.K.P. reports consulting for Genentech, Aveo, Eisai, Roche, Pfizer, Novartis, Exelixis, Ipsen, BMS and Astellas.